1. Cardiovascular deaths, non-fatal myocardial infarctions, and hospitalization due to heart failure occurred more frequently in patients with coronary heart ...
1. 12-months after randomization, the de-escalation group met the criteria for superiority (p=0.0001) with respect to the composite primary outcome ...
1. The use of coronary artery calcium scoring was associated with significant improvements in the reclassification and discrimination of incident ...
1. In this cohort study, 91% of patients with preserved ejection fraction heart failure had evidence of epicardial coronary artery ...
![Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Taxus_stent_FDA-e1607803635904-350x250.jpg)
1. The rate of clinical events and all-cause mortality was similar in patients with drug-coated balloon therapy compared to those ...
1. Among patients who have received a saphenous vein graft during coronary bypass surgery and later experience treatment failure, deployment ...
1. Patients who received low-dose colchicine daily had a ~30% lower risk of cardiovascular events compared to those who received ...
1. Patients status-post placement of drug-eluting stents (DES) for acute coronary syndrome received three months of Ticagrelor and Aspirin dual-antiplatelet ...
1. There is no significant difference in 30-day all-cause mortality between radial and femoral access for percutaneous coronary intervention (PCI) ...
1. In this analysis of data from a prospective cohort of young adults, increased mean systolic blood pressure (SBP) and ...
